Organization | Insight Therapeutics, LLC

Insight Therapeutics, LLC Report issue

For profit Phase 4

Founded: Norfolk VA United States (1996)

Organization Overview

First Clinical Trial

2012

NCT01720277

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Insight Therapeutics, LLC

Active Ingredients

Drugs in Phase 4 Trials (4)

baloxavir marboxil (xofluza) (1 trial)

inactivated influenza vaccine (4 trials)

oseltamivir (tamiflu) (1 trial)

recombinant influenza vaccine (Flublok) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Influenza, Human (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 4